While this study demonstrated the ability to differentiate IDH mutant from IDH wildtype gliomas, unfortunately further molecular subtyping of diffuse gliomas, including 1p19q codeletion status was not included as independent groups. The gene discussed is IDH1; the disease is central nervous system cancer.